Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityNo recent work listed

Ting Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6446-4056; OpenAlex author ID A5100427889. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

  1. LIPH contributes to glycolytic phenotype in pancreatic ductal adenocarcinoma by activating LPA/LPAR axis and maintaining ALDOA stability. Co-author DOI 10.1186/s12967-023-04702-6↗
  2. The glucosylceramide synthase inhibitor PDMP sensitizes pancreatic cancer cells to MEK/ERK inhibitor AZD-6244. Co-author DOI 10.1016/j.bbrc.2014.12.019↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Cheng Xiong · 1 shared paper, 2023 · strength 0.16
  2. Zhichong Wu · 1 shared paper, 2023 · strength 0.16
  3. Lingxi Jiang · 1 shared paper, 2023 · strength 0.16
  4. Xiaozhu Lin · 1 shared paper, 2023 · strength 0.16
  5. Youwei Zhu · 1 shared paper, 2023 · strength 0.16
  6. Lijie Han · 1 shared paper, 2023 · strength 0.16
  7. Meilin Xue · 1 shared paper, 2023 · strength 0.16
  8. Hao Chen · 1 shared paper, 2023 · strength 0.16
  9. Baiyong Shen · 1 shared paper, 2023 · strength 0.16
  10. Pingping Hui · 1 shared paper, 2015 · strength 0.06
  11. Jiali Ma · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.